Keyphrases
NUP98-HOXA9
33%
In Vitro Anticancer Activity
33%
DEK-NUP214
33%
Solanum Torvum Swartz
33%
COL12A1
33%
Chromosome 9
33%
NUP214
33%
Variant Translocation
33%
Human mAb
33%
Complex Variants
33%
Methyl Caffeate
33%
Diagnostic Specimen
33%
Streptomyces Olivochromogenes
33%
Antimicrobial Properties
33%
Epstein-Barr Virus-positive mucocutaneous Ulcer
33%
DNA Detection
33%
Hematopoietic Function
33%
Serum IgG Level
33%
Relapsed Lymphoma
33%
CBDCA
33%
R-CHOP Therapy
33%
Combination of Therapies
33%
System Restoration
33%
9,10-anthraquinone
33%
Severe Hepatitis
33%
CHOP Chemotherapy
33%
Rituximab-CHOP
33%
COX-2 Inhibition
33%
Antiviral Prophylaxis
33%
Acute Myeloblastic Leukemia
33%
Suboptimal Response
33%
Successful Pregnancy
33%
VPS13B
33%
Cohen Syndrome
33%
Bystander Cells
33%
Mannich Derivatives
33%
Anticancer Properties
33%
Varicella Outbreak
33%
T Cell Receptor-like Antibody
33%
Rituximab-containing Chemotherapy
33%
Lymphoma Patients
33%
Antibody-antigen
33%
Fusion Transcript
33%
ETV6
33%
B-cell Lymphoma
33%
Induction Chemotherapy
33%
Major Molecular Response
25%
MCF-7 Cells
23%
Calvert Formula
19%
Induction Therapy
19%
Pharmacology, Toxicology and Pharmaceutical Science
Rituximab
100%
Chronic Myeloid Leukemia
66%
Imatinib
66%
Antiproliferative Activity
55%
Cytochrome C
42%
Caspase
38%
Diffuse Large B Cell Lymphoma
37%
Ifosfamide
33%
Carboplatin
33%
B Cell Lymphoma
33%
Antiviral Therapy
33%
Membrane Antigen
33%
Hepatitis B Virus
33%
Protein Kinase Fer
33%
Caffeic Acid
33%
Solanum Torvum
33%
Dexamethasone
33%
Janus Kinase
33%
Combination Therapy
33%
Anthraquinone
33%
T Lymphocyte Receptor
33%
Chemotherapy
33%
Nonhodgkin Lymphoma
33%
Etoposide
33%
Caspase 3
20%
Acute Leukemia
16%
Acute Lymphoblastic Leukemia
16%
Acetic Acid Ethyl Ester
14%
Colorectal Cancer
12%
Herpes Zoster
11%
Mouse Model
11%
Tumor Growth
11%
Liver Cell Carcinoma
11%
Antitumor Activity
11%
Ribosome Protein
11%
Cytochrome C3
11%
Hexane
9%
Methanol
9%
Entecavir
7%
Malignant Neoplasm
7%
Varicella Zoster Virus
7%
Congenital Malformation
6%
Teratogenicity
6%
Minimum Bactericidal Concentration
5%
Micromonospora
5%
